A Novel Glycine Receptor Variant with Startle Disease Affects Syndapin I and Glycinergic Inhibition
Georg Langlhofer(University of Würzburg), Carmen Villmann(University of Würzburg)
Cited by 14
Related Papers
<scp>Glycine Receptor</scp> Autoantibodies Impair Receptor Function and Induce Motor Dysfunction
|Annals of Neurology|2020|48
Disruption of a Structurally Important Extracellular Element in the Glycine Receptor Leads to Decreased Synaptic Integration and Signaling Resulting in Severe Startle Disease
|Journal of Neuroscience|2017|17
Novel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle Disease
|Frontiers in Molecular Neuroscience|2021|11
Disturbances of Ligand Potency and Enhanced Degradation of the Human Glycine Receptor at Affected Positions G160 and T162 Originally Identified in Patients Suffering from Hyperekplexia
|Frontiers in Molecular Neuroscience|2015|10
The GlyR Extracellular β8–β9 Loop – A Functional Determinant of Agonist Potency
|Frontiers in Molecular Neuroscience|2017|5